Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (6): 1065-1067. doi: 10.19723/j.issn.1671-167X.2022.06.001
适 陈*(
),田 刘
CLC Number:
- R593.2
| 1 |
Kitching AR , Anders HJ , Basu N , et al. ANCA-associated vasculitis[J]. Nat Rev Dis Primers, 2020, 6 (1): 71.
doi: 10.1038/s41572-020-0204-y |
| 2 | Aladdin JM . An update on the epidemiology of ANCA-associated vasculitis[J]. Rheumatology (Oxford), 2020, 59 (Suppl 3): 42- 50. |
| 3 | Gary SF , Ralph CB , Sherine EG , et al. Kelley & Firestein's textbook of rheumatology[M]. 11th. Philadelphia: Elsevier, 2020: 1485. |
| 4 | 余洁, 陈适, 栗占国. 抗中性粒细胞胞浆抗体阳性患者疾病谱分析[J]. 中华全科医师杂志, 2010, 9 (1): 26- 30. |
| 5 |
赵明辉. 抗中性粒细胞胞质抗体相关小血管炎诊断和治疗中的问题与对策[J]. 中华风湿病学杂志, 2009, 13 (4): 217- 219.
doi: 10.3760/cma.j.issn.1007-7480.2009.04.001 |
| 6 |
Buttgereit F , Dejaco C , Matteson EL , et al. Polymyalgia rheumatica and giant cell arteritis: A systematic review[J]. JAMA, 2016, 315 (22): 2442- 2458.
doi: 10.1001/jama.2016.5444 |
| 7 | Yanaoka H , Nagafuchi Y , Hanata N , et al. Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls[J]. J Autoimmun, 2021, 119 (5): 102617. |
| 8 |
Chen Z , Zhao YY , Wang Q , et al. Imaging features of 18FFDG PET/CT in different types of systemic vasculitis[J]. Clin Rheumatol, 2022, 41 (5): 1499- 1509.
doi: 10.1007/s10067-021-06039-1 |
| 9 |
Robson JC , Grayson PC , Ponte C , et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis[J]. Ann Rheum Dis, 2022, 81 (3): 315- 320.
doi: 10.1136/annrheumdis-2021-221795 |
| 10 | Suppiah R , Robson JC , Grayson PC , et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis[J]. ArthritisRheumatol, 2022, 74 (3): 400- 406. |
| 11 |
Jones RB , Tervaert JW , Hauser T , et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis[J]. N Engl J Med, 2010, 363 (3): 211- 220.
doi: 10.1056/NEJMoa0909169 |
| 12 |
Michael W , Peter AM , Chen AP , et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis[J]. N Engl J Med, 2020, 382 (7): 622- 631.
doi: 10.1056/NEJMoa1803537 |
| 13 |
de Groot K , Rasmussen N , Bacon PA , et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Rheum, 2005, 52 (8): 2461- 2469.
doi: 10.1002/art.21142 |
| 14 |
Guillevin L , Pagnoux C , Karras A , et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis[J]. N Engl J Med, 2014, 371 (19): 1771- 1780.
doi: 10.1056/NEJMoa1404231 |
| 15 |
Pagnoux C , Mahr A , Hamidou MA , et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis[J]. N Engl J Med, 2008, 359 (26): 2790- 2803.
doi: 10.1056/NEJMoa0802311 |
| 16 | Goglin S , Chung SA . New developments in treatments for systemic vasculitis[J]. Curr Opin Pharmacol, 2022, 66 (10): 102270. |
| 17 |
Sharon AC , Carol AL , Mehrdad M , et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Care Res(Hoboken), 2021, 73 (8): 1088- 1105.
doi: 10.1002/acr.24634 |
| 18 |
Michael EW , Praveen A , David J , et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis[J]. N Engl J Med, 2017, 376 (20): 1921- 1932.
doi: 10.1056/NEJMoa1702079 |
| 19 | David RJ , Peter AM , Thomas JS , et al. Avacopan for the treatment of ANCA-associated vasculitis[J]. N Engl J Med, 2021, 384 (7): 599- 609. |
| 20 | Maz M , Chung SA , Abril A , et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu arteritis[J]. Arthritis Rheumatol, 2021, 73 (8): 1349- 1365. |
| 21 | He J , Zhang R , Shao M , et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial[J]. Ann Rheum Dis, 2020, 79 (1): 141- 149. |
| 22 | Michelle R , Roberta L , Patrice C , et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial[J]. Ann Rheum Dis, 2019, 78 (2): 209- 217. |
| 23 | Carol AL , David C , Steven RY , et al. A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis[J]. Arthritis Rheumatol, 2017, 69 (4): 837- 845. |
| 24 | Nils V , Wolfgang AS , Peter L , et al. Efficacy and safety of secukinumab in patients with giant cell arteritis: Study protocol for a randomized, parallel group, double-blind, placebo-controlled phase Ⅱ trial[J]. Trials, 2021, 22 (1): 543. |
| 25 | Kong XF , Sun Y , Dai XJ , et al. Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: A prospective observational study[J]. Ann Rheum Dis, 2022, 81 (1): 117- 123. |
| [1] | Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312. |
| [2] | Jiyan CHU, Ping LI, Jing TIAN, Diyu FU, Lin GUO, Rui SUN, Yadi LI. Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 175-183. |
| [3] | Yuan LIU, Guixiu SHI. Change from Sjögren syndrome to Sjögren disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1015-1017. |
| [4] | Yirui LIAN, Jingxuan LIU, Liang ZHAO, Jing ZHAO, Sitian ZANG, Yuhui LI. Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1018-1023. |
| [5] | Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031. |
| [6] | Wenhao LIN, Yang XIE, Fangqing WANG, Shuying WANG, Xiangjun LIU, Fanlei HU, Yuan JIA. Single-cell RNA sequencing of B cells reveals molecular typing in Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1032-1041. |
| [7] | Zhao XIANG, Li YANG, Jing YANG. Untargeted metabolomics reveals differential serum metabolites and metabolic pathways in patients with primary Sjögren syndrome and thrombocytopenia [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1042-1050. |
| [8] | Yayun ZHAO, Mengfan NI, Xue LI, Bei WANG, Gong CHENG, Jing HE, Yuebo JIN. Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1051-1060. |
| [9] | Jiajing PENG, Li CUI. Clinical features and prognosis of sarcoidosis with ocular lesions as the initial manifestation [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1061-1066. |
| [10] | Yajing GAO, Zhengfang LI, Mengsi MA, Lijun WU. Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1067-1073. |
| [11] | Xiaolin WANG, Shaoyi GUO, Dazhao CHEN, Xijie WEN, Yong HUA, Liang ZHANG, Qin ZHANG. A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1081-1088. |
| [12] | Xinfeng WU, Siliang MAN, Dazhao CHEN, Yong HUA, Xijie WEN, Yingyue DING, Liang ZHANG, Xiujuan HOU. A long-term review for radiographic parameters of hips in axial spondyloarthritis patients with end-stage hip involvement: A 24-year trend analysis from a single high-volume tertiary center [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1089-1095. |
| [13] | Jingwen LAN, Zhe CHEN, Yongjing CHENG, Like ZHAO. Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1101-1106. |
| [14] | Yanyan LI, Xiangjun LIU, Gongming LI, Chun LI, Yuan JIA. Clinic behavior and therapeutic status of patients with antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1107-1112. |
| [15] | Chun WEI, Yue YANG, Xinju ZHAO, Xu LIU, Yuan JIA. Systemic lupus erythematosus complicated by autoimmune nodopathy: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1174-1179. |
|
||